Class 4 Drug Alert (caution in use): Pregabalin 75mg capsules - incorrect strength printed in one area of foil blister pack
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 4 drug alert: medicines defect information (caution in use) for a specified batch of pregabalin 75mg capsules manufactured by Teva UK. The strength is printed in several positions on the foil lid of the blisters. For affected units, the strength is printed incorrectly, as 25mg instead of 75mg, in one position on the foil. The strength is printed correctly in the remaining positions on the foil. To ensure continuity of supply, affected stock will not be recalled.
Further details of the alert and the affected batch are available on the MHRA website.